Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Crisantaspase (Erwinase)
Connect with this vendor - Learn about this product

Crisantaspase (Erwinase)

Each ml contains 10,000 Units of Crisantaspase
It is used for Acute lymphoblastic leukemia Treatment (in combination with other chemotherapy) of acute lymphoblastic leukemia (ALL) in patients with hypersensitivity to E. coli-derived asparaginase

  • Presentation: Injection
  • Strength:  10,000 Units  
  • Pack Size: 5 Vials.
  • Pack Insert: Yes
  • Marketing Authorization Holder: Porton Biopharma Limited.
  • Manufacturing License: PL 44403/0002